60 results
Page 2 of 3
F-3
EX-23.2
233xlsw9nfom81vf14k1
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
65z39zon33
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-1.2
qo69tqxhibnn
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.5
dzouwntryd
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-15.1
qnn3rvn y1
31 Mar 22
Annual report (foreign)
4:33pm
20-F
bs9 ez3ooiff
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
l5x z3qqtx
16 Feb 22
Current report (foreign)
4:01pm
6-K
EX-99.2
e9pnimbtp0u8syy
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.3
zouzwo 0s
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
ajs0homahmjx6n qee
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
S-8
EX-23.1
xglptufgyu8fs2
19 Mar 21
Registration of securities for employees
5:13pm
424B4
ml4k6g as5n6z
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1MEF
EX-8.3
d1l367
18 Mar 21
Registration statement to add securities to prior F-1 registration
9:02pm
F-1MEF
EX-23.1
07m7l8w 2e
18 Mar 21
Registration statement to add securities to prior F-1 registration
9:02pm
F-1MEF
EX-8.2
uqhjwmh5gjjgn2
18 Mar 21
Registration statement to add securities to prior F-1 registration
9:02pm
F-1/A
EX-23.1
gw749npljcab5wu
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
tzcoxg
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-99.2
i0u a3q0m6
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
EX-10.3
s6r0w1 6j5nzn
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
EX-8.3
syj 7jl7ovv3i2lm0xb2
17 Mar 21
Registration statement (foreign) (amended)
6:38am